GlassScriptPhysician profile
Minesh Desai
NPI 1952600637
$640.00
in general payments reported to CMS, 2019-2025
14 companies · $49.55 in 2025
The $49.55 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2022: $163 · 2023: $233 · 2024: $18.01 · 2025: $49.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $300.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.27 | 2019 | |
| Novo Nordisk INC | $121.86 | 2023 | Wegovy |
| Glaxosmithkline, LLC. | $67.96 | 2022-2023 | Shingrix, Bexsero |
| Pfizer INC. | $50.76 | 2019-2022 | |
| Amgen INC. | $49.55 | 2025 | Otezla, Repatha |
| Biosense Webster, INC. | $38.12 | 2023 | Carto 3 |
| Boston Scientific Corporation | $35.42 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $29.25 | 2022 | |
| Dynavax Technologies Corporation | $28.29 | 2022 | |
| Genentech USA, INC. | $23.34 | 2019 | |
| Inspire Medical Systems, INC. | $22.40 | 2023 | Inspire |
| Janssen Biotech, INC. | $18.01 | 2024 | Rybrevant |
| Exact Sciences Corporation | $17.53 | 2023 | Cologuard Collection Kit |
| Abbvie INC. | $15.24 | 2023 | Qulipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Minesh Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.